2021
DOI: 10.3390/m1207
|View full text |Cite
|
Sign up to set email alerts
|

Methyl 2-Amino-4-[1-(tert-butoxycarbonyl)azetidin-3-yl]-1,3-selenazole-5-carboxylate

Abstract: Methyl 2-amino-4-[1-(tert-butoxycarbonyl)azetidin-3-yl]-1,3-selenazole-5-carboxylate as a newly functionalized heterocyclic amino acid was obtained via [3+2] cycloaddition. The structure of the novel 1,3-selenazole was unequivocally confirmed by detailed 1H, 13C, 15N, and 77Se NMR spectroscopic experiments, HRMS and elemental analysis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 18 publications
0
4
0
Order By: Relevance
“…The synthetic strategy for the synthesis of novel functionalized 1,2-oxazole derivatives is outlined in Scheme 1. The synthetic sequence began with preparing β-keto esters 2a-h by treating N-Boc-protected cyclic amino acids 1a-h with Meldrum's acid in the presence of EDC•HCl and DMAP, followed by methanolysis of the corresponding adducts [27,28,31,[36][37][38]. Reaction of the resulting β-keto esters 2a-h with N,N-dimethylformamide dimethylacetal afforded cycloaminyl β-enamino ketoesters 3a-h. After isolation of compounds 3a-h from the corresponding reaction mixtures, they were identified using LC-MS analysis, and were immediately treated with hydroxylamine hydrochloride in an appropriate solvent to obtain the target 1,2oxazoles 4a-h. A representative β-enamino ketoester 3a was subjected to a detailed NMR analysis (Figure 2a).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The synthetic strategy for the synthesis of novel functionalized 1,2-oxazole derivatives is outlined in Scheme 1. The synthetic sequence began with preparing β-keto esters 2a-h by treating N-Boc-protected cyclic amino acids 1a-h with Meldrum's acid in the presence of EDC•HCl and DMAP, followed by methanolysis of the corresponding adducts [27,28,31,[36][37][38]. Reaction of the resulting β-keto esters 2a-h with N,N-dimethylformamide dimethylacetal afforded cycloaminyl β-enamino ketoesters 3a-h. After isolation of compounds 3a-h from the corresponding reaction mixtures, they were identified using LC-MS analysis, and were immediately treated with hydroxylamine hydrochloride in an appropriate solvent to obtain the target 1,2oxazoles 4a-h. A representative β-enamino ketoester 3a was subjected to a detailed NMR analysis (Figure 2a).…”
Section: Resultsmentioning
confidence: 99%
“…The synthetic strategy for the synthesis of novel functionalized 1,2-oxazole derivatives is outlined in Scheme 1 . The synthetic sequence began with preparing β-keto esters 2a – h by treating N -Boc-protected cyclic amino acids 1a – h with Meldrum’s acid in the presence of EDC·HCl and DMAP, followed by methanolysis of the corresponding adducts [ 27 28 31 , 36 – 38 ]. Reaction of the resulting β-keto esters 2a – h with N , N -dimethylformamide dimethylacetal afforded cycloaminyl β-enamino ketoesters 3a – h .…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…[40] In our recent work, we have been pursuing the construction of amino acid-like functionalized heterocyclic molecules possessing azetidine core. [41][42][43][44] In this study, we prepared a library of 3-aryl-3-azetidinyl acetic acid methyl ester derivatives, assessed their acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activity, and determined their neuroprotective effect in salsolinol (SAL)-induced model of PD and glutamate (Glu)-induced model of oxidative damage on neuron-like SH-SY5Y cells. Consequently, cholinesterase inhibition, alongside neuroprotective effect in Gluinduced Xc-antiporter inhibition models could offer a new strategy for disease-modifying AD and PD therapy.…”
Section: Introductionmentioning
confidence: 99%